This invention relates to an aqueous formulation of pirenoxine that can inhibit the pirenoxine from adhering to the container.The aqueous formulation of pirenoxine comprises at least polyoxyethylene hydrogenated castor oil and/or Trometamol to inhibit the pirenoxine from adhering to the container.本發明係相關於抑制懸浮型水性液劑中的吡諾克辛(Pirenoxine)黏著於容器。使懸浮型水性液劑中含有至少1種選自聚氧乙烯氫化蓖麻油及妥曼他莫(trometamol)所成之群組,藉此可抑制吡諾克辛黏著於容器。